-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Brimonidine Tartrate + Carbachol) in Presbyopia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Brimonidine Tartrate + Carbachol) in Presbyopia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Brimonidine Tartrate + Carbachol) in Presbyopia Drug Details: Brimonidine tartrate...
-
Product Insights
Cataract – Drugs In Development, 2023
Global Markets Direct’s, ‘Cataract - Drugs In Development, 2023’, provides an overview of the Cataract pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cataract, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Presbyopia – Drugs In Development, 2023
Global Markets Direct’s, ‘Presbyopia - Drugs In Development, 2023’, provides an overview of the Presbyopia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Presbyopia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Ocular Hypertension – Drugs In Development, 2023
Global Markets Direct’s, ‘Ocular Hypertension - Drugs In Development, 2023’, provides an overview of the Ocular Hypertension pipeline landscape. The report provides comprehensive information on the therapeutics under development for Ocular Hypertension, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Glaucoma – Drugs In Development, 2023
Global Markets Direct’s, ‘Glaucoma - Drugs In Development, 2023’, provides an overview of the Glaucoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Glaucoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DC-6001 in Metastatic Hepatocellular Carcinoma (HCC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DC-6001 in Metastatic Hepatocellular Carcinoma (HCC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.DC-6001 in Metastatic Hepatocellular Carcinoma (HCC) Drug Details:DC-6001 is under development...
-
Product Insights
Medical Imaging Information Systems Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
Medical Imaging Information Systems Pipeline Market Report Overview Medical imaging information systems are used in hospitals and diagnostic imaging centers to store, retrieve, modify, and forward images and information to hospital departments or imaging centers over a network. The Medical Imaging Information Systems pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress,...
-
Product Insights
Presbyopia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Presbyopia Pipeline Drugs Market Report Overview Presbyopia is an eye condition in which the eye slowly loses the ability to focus quickly on close objects. Presbyopia happens in people as they age. Signs and symptoms include headaches, eyestrain, difficulty reading small print, and fatigue. Risk factors include anemia, diabetes, cardiovascular disease, hyperopia, multiple sclerosis, myasthenia gravis, and eye trauma. The Presbyopia pipeline drugs market research report provides comprehensive information on the therapeutics under development for Presbyopia, complete with analysis by...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – (brimonidine tartrate + carbachol)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry (brimonidine tartrate + carbachol) Drug Details Brimonidine tartrate in combination with carbachol (VTI-001) is...